MedPath

Evaluation of Efficacy of Shwasahara Dashemani vati in the management of Tamaka Shwasa

Phase 3
Completed
Conditions
Health Condition 1: J988- Other specified respiratory disorders
Registration Number
CTRI/2019/01/017259
Lead Sponsor
Director IPGT and RA GAU JAMNAGAR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

1 Patients of 2 â?? 14 years of age group of either sex

2 Diagnosed cases of Tamaka Shwasa (Bronchial Asthma) with at

least 2 episodes of asthma symptoms during the previous year

3 Patients on other drug therapy will be included only after

completion of wash out period of 2 weeks

4 Mild persistent asthmatic patients

5 Patients on other drug therapy will be included only after

completion

Exclusion Criteria

Children of age below 2 years and above 14 years

2 Patients with status asthmatics Evidence of active Concomitant

Pulmonary Diseases other than

asthma

3 Evidence of requirement of intubations for asthma or had been

hospitalized for asthma within one month before Unresolved Sinus

Disease or an unresolved upper or lower respiratory tract infection

within 4 weeks

4 Concomitant severe de-compensated systemic disease

(cardiovascular renal hepatic endocrine hematological neurological

immunological).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
relieve in the sign and symptom of shwasa roga <br/ ><br>or Bronchial asthmaTimepoint: 8 week
Secondary Outcome Measures
NameTimeMethod
To prevent the recurrence of attack of <br/ ><br>breathlessness <br/ ><br>To increase the immunity against allergensTimepoint: 4 week
© Copyright 2025. All Rights Reserved by MedPath